Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARCT | AMGN | BMY | GILD | VRTX |
| Company | Arcturus Therapeutics Ltd | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 14.70 | 269.00 | 56.22 | 90.92 | 395.72 |
| High | 15.80 | 269.61 | 57.05 | 93.29 | 401.31 |
| Low | 14.61 | 262.21 | 56.08 | 90.71 | 386.49 |
| Last | 15.45 | 267.13 | 56.73 | 92.92 | 398.83 |
| Change | +0.61 | +5.94 | +0.43 | +1.83 | +2.19 |
| % Change | +4.11% | +2.27% | +0.76% | +2.01% | +0.55% |
| Volume | 217,344 | 3,639,951 | 9,417,458 | 4,383,462 | 2,458,028 |
| 20-Day Average Volume | 381,687 | 4,653,350 | 9,855,825 | 6,676,273 | 1,623,121 |
| Previous Close | 14.84 | 261.19 | 56.30 | 91.09 | 396.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.25 | 275.26 | 57.96 | 92.00 | 457.09 |
| 20-Day Raw Stochastic | 19.34% | 33.90% | 32.54% | 73.09% | 22.31% |
| 20-Day Relative Strength | 40.77% | 36.80% | 51.11% | 56.38% | 30.39% |
| Weighted Alpha | -58.70 | -12.34 | +16.65 | +26.42 | -10.38 |
| Today's Opinion | 100% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 80% Buy | 88% Buy | 56% Sell |
| Last Month's Opinion | 100% Sell | 40% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.47% since 12/13/24 | -0.89% since 12/13/24 | +1.96% since 12/13/24 | +1.43% since 12/13/24 | -13.78% since 12/13/24 |
| Low | 14.30 on 12/19/24 | 253.30 on 12/19/24 | 55.68 on 12/16/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 17.48 on 12/16/24 | 272.69 on 12/16/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 | 474.18 on 12/17/24 |
| 1-Month | |||||
| %Chg | -3.65% since 11/20/24 | -6.82% since 11/20/24 | -1.74% since 11/20/24 | +5.12% since 11/20/24 | -11.39% since 11/20/24 |
| Low | 14.30 on 12/19/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 88.07 on 11/21/24 | 377.85 on 12/19/24 |
| High | 20.92 on 12/06/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -24.41% since 09/20/24 | -20.50% since 09/20/24 | +15.11% since 09/20/24 | +11.00% since 09/20/24 | -14.00% since 09/20/24 |
| Low | 14.30 on 12/19/24 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 25.88 on 10/02/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -41.41% since 06/20/24 | -13.45% since 06/20/24 | +38.58% since 06/20/24 | +36.03% since 06/20/24 | -15.17% since 06/20/24 |
| Low | 14.30 on 12/19/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 28.05 on 06/24/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 401,971 | 140,398,256 | 114,186,360 | 113,522,360 | 102,146,304 |
| Shares Outstanding, K | 27,087 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 166,800,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -29,730,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 41,670,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -6,900,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 2.62 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 11/07/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/07/24 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | 01/04/13 | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.46 | 48.58 | 20.47 | 0.00 |